Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChristie Regulatory News (CTG)

Share Price Information for Christie (CTG)

Share Price is delayed by 15 minutes
Get Live Data
142.50    0.00 (0.00%)
Bid:
135.00
Ask:
150.00
Spread: 15.00 (11.111%)
Market Cap: £35.24m
CTG Live PriceLast checked at - London Stock Exchange

Intraday Christie Share Chart

Holding(s) in Company

17 Jun 2026 07:01

RNS Number : 5637I
Christie Group PLC
17 June 2026
 

 

TR-1: Standard form for notification of major holdings

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ISIN: GB0001953156

Issuer Name: Christie Group plc

1b. Please indicate if the issuer is a non-UK issuer

Non-UK issuer

2. Reason for the notification

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Details of person subject to the notification obligation

Name

Philip Hammond Rhys Gwyn

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached:

16 June 2026

6. Date on which issuer notified (DD/MM/YYYY):

16 June 2026

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B)

Resulting situation on the date on which threshold was crossed or reached

0.00%

0.00%

0.00%

0

Position of previous notification (if

applicable)

27.93%

0.00

27.93%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB0001953156

0

0

0.00%

0.00%

SUBTOTAL 8. A

0

0.00%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Physical or cash

Settlement

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information

 

Place of completion

London

Date of completion

16 June 2026

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEAFKKFEFKEAA
Date   Source Headline
17th Jun 20267:01 amRNSHolding(s) in Company
17th Jun 20267:01 amRNSHolding(s) in Company
17th Jun 20267:00 amRNSResult of AGM
16th Jun 20267:00 amRNSAGM Trading Update
22nd May 20269:00 amRNS2025 Annual Report and AGM Notice
30th Apr 20263:36 pmRNSPDMR Notification
27th Apr 20267:00 amRNSPreliminary Results
17th Apr 20267:00 amRNSNotice of Results and Investor Presentation
2nd Apr 20267:00 amRNSClosure of final salary pension schemes
6th Mar 20263:43 pmRNSPDMR Notification
6th Feb 20261:20 pmRNSDirector / PDMR Shareholding
19th Jan 20267:00 amRNSFull Year Trading Update
19th Jan 20267:00 amRNSCompletion of Vennersys sale
23rd Dec 20257:00 amRNSTrading Update
23rd Dec 20257:00 amRNSTrading Update
22nd Dec 20257:00 amRNSSale of Vennersys
22nd Dec 20257:00 amRNSSale of Vennersys
8th Oct 202512:14 pmRNSResilient Market Conditions in Key Sectors
29th Sep 20257:00 amRNSInterim Results
23rd Jul 20257:00 amRNSMid Year Reviews
1st Jul 202512:32 pmRNSChristie & Co advises on sale of Vienna Marriot
12th Jun 20253:04 pmRNSResult of AGM
12th Jun 20257:00 amRNSAGM Trading Update
20th May 20259:38 amRNSHolding(s) in Company
16th May 20259:00 amRNS2024 Annual Report and AGM Notice
8th May 202510:42 amRNSChristie & Co celebrates 90th anniversary
28th Apr 20257:00 amRNSPreliminary Results
21st Jan 20257:00 amRNSFull Year Trading Update
10th Jan 202512:26 pmRNSHolding(s) in Company
6th Nov 20244:33 pmRNSDirector/PDMR Shareholding
5th Nov 20247:00 amRNSDisposal of Orridge Holdings Limited
30th Sep 20247:00 amRNSInterim Results
26th Sep 20247:00 amRNSDirectorate Change
18th Sep 20247:00 amRNSTrading Statement
13th Jun 202412:06 pmRNSResult of AGM
13th Jun 20247:00 amRNSAGM Trading Update
5th Jun 20249:46 amRNSHolding(s) in Company
17th May 20249:00 amRNS2023 Annual Report and AGM Notice
30th Apr 20242:19 pmRNSDirector/PDMR Shareholding
29th Apr 20247:00 amRNSFinal Results
10th Apr 20247:00 amRNSDate of Preliminary Statement of Results
15th Feb 20247:00 amRNSTrading Statement
5th Feb 20249:00 amRNSChristie & Co facilitates charitable trust merger
22nd Jan 20247:00 amRNSChristie & Co broker sale of London day nursery
8th Dec 20237:00 amRNSTrading Statement
30th Nov 20237:00 amRNSChristie & Co Care wins at the LaingBuisson Awards
30th Nov 20237:00 amRNSChristie & Co 'team of the year' at dental awards
27th Oct 20237:00 amRNSChristie & Co instructed to market caravan parks
18th Oct 20237:00 amRNSChristie & Co publish key market insights
13th Oct 20237:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.